Rapid Tophus Resolution in Chronic Refractory Gout Patients Treated with Pegloticase

被引：0
|
作者：
Mandell, Brian F. [1 ]
Baraf, Herbert S. B. [2 ]
Yeo, Anthony [3 ]
Lipsky, Peter E. [4 ]
机构：
[1] Cleveland Clin, Rheumatol, Cleveland, OH 44106 USA
[2] Ctr Rheumatol & Bone Res, Wheaton, MD USA
[3] Horizon Pharma, Lake Forest, IL USA
[4] AMPEL BioSolut LLC, Charlottesville, VA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2054
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Allopurinol efficacy in patients with tophus gout and chronic renal failure
    Yakunina, I. A.
    Barskova, V. G.
    Nasonova, V. A.
    TERAPEVTICHESKII ARKHIV, 2006, 78 (06) : 88 - +
  • [32] Characterization of patients with chronic refractory gout who do and do not have clinically apparent tophi and their response to pegloticase
    Edwards, N. Lawrence
    Singh, Jasvinder A.
    Troum, Orrin
    Yeo, Anthony E.
    Lipsky, Peter E.
    RHEUMATOLOGY, 2019, 58 (08) : 1422 - 1431
  • [33] TOPHUS RESOLUTION WITH PEGLOTICASE A PROSPECTIVE DUAL ENERGY COMPUTED TOMOGRAPHY STUDY
    Schett, G.
    Araujo, E.
    Bayat, S.
    Petsch, C.
    Englbrecht, M.
    Faustini, F.
    Kleyer, A.
    Hueber, A.
    Cavallaro, A.
    Lell, M.
    Dalbeth, N.
    Manger, B.
    Rech, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 769 - 770
  • [34] Pegloticase: A Novel Agent for Treatment-Refractory Gout
    Shannon, Jennifer A.
    Cole, Sabrina W.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (03) : 368 - 376
  • [35] CHARACTERIZATION OF PATIENTS WITH CHRONIC REFRACTORY GOUT WHO DO AND DO NOT HAVE CLINICALLY APPARENT TOPHI: RESPONSE TO PEGLOTICASE
    Edwards, N. L.
    Singh, J.
    Troum, O.
    Yeo, A.
    Lipsky, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 377 - 377
  • [36] Tophus resolution with pegloticase: a prospective dual-energy CT study
    Araujo, Elizabeth G.
    Bayat, Sara
    Petsch, Christina
    Englbrecht, Matthias
    Faustini, Francesca
    Kleyer, Arnd
    Hueber, Axel J.
    Cavallaro, Alexander
    Lell, Michael
    Dalbeth, Nicola
    Manger, Bernhard
    Schett, Georg
    Rech, Juergen
    RMD OPEN, 2015, 1 (01):
  • [37] Pegloticase reduces serum urate levels in patients with treatment-refractory gout
    Nature Clinical Practice Rheumatology, 2008, 4 (12): : 624 - 624
  • [38] Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment Two Randomized Controlled Trials
    Sundy, John S.
    Baraf, Herbert S. B.
    Yood, Robert A.
    Edwards, N. Lawrence
    Gutierrez-Urena, Sergio R.
    Treadwell, Edward L.
    Vazquez-Mellado, Janitzia
    White, William B.
    Lipsky, Peter E.
    Horowitz, Zeb
    Huang, William
    Maroli, Allan N.
    Waltrip, Royce W., II
    Hamburger, Steven A.
    Becker, Michael A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (07): : 711 - 720
  • [39] The Needle or Knife Pegloticase for Refractory Crippling Gout in a Nonagenarian
    Choi, Noah
    Eickhoff, Jeffrey
    Keith, Michael
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2017, 23 (06) : 343 - 343
  • [40] Pegloticase Treatment Significantly Decreases Blood Pressure in Patients With Chronic Gout
    Johnson, Richard J.
    Choi, Hyon K.
    Yeo, Anthony E.
    Lipsky, Peter E.
    HYPERTENSION, 2019, 74 (01) : 95 - 101
12345